logo

For the Inventor, By the Inventor

Tucson, AZ, United States of America

Werner Tückmantel

This inventor holds 4 USPTO granted patents. Top assignee: Mars, Incorporated. Active years: 2006-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Werner Tückmantel. Retrieved from https://idiyas.com/inventor/werner-tückmantel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4

Average Co-Inventor Count = 3.2

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Washington, DC (US) (2006)
  • Tucson, AZ (US) (2006 - 2009)

Company Filing History:

goldMedal4 out of 1,226 
 
Mars, Incorporated
 patents

Years Active: 2006-2009

Loading Chart...
4 patents (USPTO):Explore Patents
1. 7507831 - Tetra- and penta-o-benzyl-protected, C-4 activated-epicatechin and -catechin monomers and processes for their preparation and use (2009-03-24),
2. 7244855 - Synthesis of oligomeric epicatechin and catechin-derived procyanidins (2007-07-17),
3. 7126014 - Synthesis of epecatechin-4α, 8-epicatechin and -catechin dimers and derivatives thereof (2006-10-24),
4. 7067679 - Synthesis of dimeric, trimeric, tetrameric pentameric, and higher oligomeric epicatechin-derived procyanidins having 4,8-interflavan linkages and their use to inhibit cancer cell growth through cell cycle arrest (2006-06-27),

Title: **Werner Tückmantel: Innovator in Epicatechin Chemistry**

Introduction

Werner Tückmantel is an esteemed inventor based in Tucson, Arizona, who has made significant contributions to the field of chemistry, particularly in the development of epicatechin derivatives. With a portfolio of four patents, Tückmantel's work demonstrates a deep understanding of molecular chemistry and its practical applications in health and medicine.

Latest Patents

Tückmantel's latest patents focus on various processes for preparing protected epicatechin oligomers, essential for developing potential treatments for cancer. His patent, titled "Tetra- and penta-o-benzyl-protected, C-4 activated-epicatechin and -catechin monomers and processes for their preparation and use," describes methods for coupling protected epicatechin monomers in the presence of acidic clays and silver tetrafluoroborate. This innovative approach allows for the synthesis of oligomeric epicatechin and catechin-derived procyanidins with (4,8)-interflavan linkages, highlighting the application of these compounds in fighting cancer.

Career Highlights

Werner Tückmantel currently works with Mars, Incorporated, where he applies his expertise to further advancements in chemistry. His work is characterized by creativity and a strong commitment to exploring the therapeutic potentials of natural compounds. His contributions have not only expanded the understanding of epicatechin compounds but also paved the way for their usage in medical applications.

Collaborations

Tückmantel has collaborated with notable colleagues, including Alan P. Kozikowski and Leo J. Romanczyk. These collaborations enhance the exchange of ideas and innovative approaches within their respective fields, fostering a creative environment that stimulates research and development.

Conclusion

Werner Tückmantel continues to push the boundaries of chemical research with his significant patents and collaborations. His work on epicatechin derivatives holds promise for future therapeutic applications, particularly in the treatment of cancer. As he continues his research at Mars, Incorporated, the impact of his innovations is sure to resonate in both academic and medical communities.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…